147 related articles for article (PubMed ID: 24488919)
1. Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation.
Malvasi A; Casciaro F; Minervini MM; Kosmas I; Mynbaev OA; Pacella E; Monti Condesnitt V; Creanza A; Di Renzo GC; Tinelli A
Eur Rev Med Pharmacol Sci; 2014; 18(2):270-4. PubMed ID: 24488919
[TBL] [Abstract][Full Text] [Related]
2. Can trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients?
Malvasi A; Kosmas I; Mynbaev OA; Sparic R; Gustapane S; Guido M; Tinelli A
Clin Ter; 2017; 168(4):e240-e247. PubMed ID: 28703838
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
Costantino D; Minozzi G; Minozzi E; Guaraldi C
Eur Rev Med Pharmacol Sci; 2009; 13(2):105-10. PubMed ID: 19499845
[TBL] [Abstract][Full Text] [Related]
4. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.
Matarrelli B; Vitacolonna E; D'Angelo M; Pavone G; Mattei PA; Liberati M; Celentano C
J Matern Fetal Neonatal Med; 2013 Jul; 26(10):967-72. PubMed ID: 23327487
[TBL] [Abstract][Full Text] [Related]
5. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Rizzo P; Raffone E; Benedetto V
Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):555-61. PubMed ID: 20712264
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.
Gerli S; Papaleo E; Ferrari A; Di Renzo GC
Eur Rev Med Pharmacol Sci; 2007; 11(5):347-54. PubMed ID: 18074942
[TBL] [Abstract][Full Text] [Related]
7. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
8. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
Nestler JE; Jakubowicz DJ; Reamer P; Gunn RD; Allan G
N Engl J Med; 1999 Apr; 340(17):1314-20. PubMed ID: 10219066
[TBL] [Abstract][Full Text] [Related]
9. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
Minozzi M; Nordio M; Pajalich R
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
[TBL] [Abstract][Full Text] [Related]
10. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial.
Celentano C; Matarrelli B; Pavone G; Vitacolonna E; Mattei PA; Berghella V; Liberati M
J Matern Fetal Neonatal Med; 2020 Mar; 33(5):743-751. PubMed ID: 30558466
[No Abstract] [Full Text] [Related]
11. Concomitant use of policosanol and beta-blockers in older patients.
Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
[TBL] [Abstract][Full Text] [Related]
12. Apelin levels in normal pregnancy.
Kourtis A; Gkiomisi A; Mouzaki M; Makedou K; Anastasilakis AD; Toulis KA; Gerou S; Gavana E; Agorastos T
Clin Endocrinol (Oxf); 2011 Sep; 75(3):367-71. PubMed ID: 21521329
[TBL] [Abstract][Full Text] [Related]
13. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
Pizzo A; Laganà AS; Barbaro L
Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
[TBL] [Abstract][Full Text] [Related]
14. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Croze ML; Soulage CO
Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
[TBL] [Abstract][Full Text] [Related]
15. [Factors relevant to newborn birth weight in pregnancy complicated with abnormal glucose metabolism].
Yang YD; Zhai GR; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):646-51. PubMed ID: 21092542
[TBL] [Abstract][Full Text] [Related]
16. Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.
Campbell WW; Ostlund RE; Joseph LJ; Farrell PA; Evans WJ
Horm Metab Res; 2001 Jan; 33(1):44-51. PubMed ID: 11280715
[TBL] [Abstract][Full Text] [Related]
17. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Papaleo E; Unfer V; Baillargeon JP; Fusi F; Occhi F; De Santis L
Fertil Steril; 2009 May; 91(5):1750-4. PubMed ID: 18462730
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma homocysteine levels in gestational diabetes mellitus.
Tarim E; Bagis T; Kilicdag E; Erkanli S; Aslan E; Sezgin N; Kuscu E
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):543-7. PubMed ID: 15144335
[TBL] [Abstract][Full Text] [Related]
19. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
[TBL] [Abstract][Full Text] [Related]
20. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
Ho SC; Chen YM; Ho SS; Woo JL
Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]